5 Stocks Pushing The Health Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 112 points (-0.7%) at 15,897 as of Tuesday, Dec. 3, 2013, 11:45 AM ET. The NYSE advances/declines ratio sits at 970 issues advancing vs. 1,886 declining with 143 unchanged.

The Health Services industry currently sits down 0.1% versus the S&P 500, which is down 0.4%. On the negative front, top decliners within the industry include Grifols ( GRFS), down 1.8%, WellPoint ( WLP), down 1.4%, Agilent Technologies ( A), down 1.0%, Covidien ( COV), down 0.8% and Express Scripts ( ESRX), down 0.6%. A company within the industry that increased today was St Jude Medical ( STJ), up 0.8%.

TheStreet would like to highlight 5 stocks pushing the industry lower today:

5. Stryker Corporation ( SYK) is one of the companies pushing the Health Services industry lower today. As of noon trading, Stryker Corporation is down $0.60 (-0.8%) to $73.66 on light volume. Thus far, 316,630 shares of Stryker Corporation exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $73.63-$74.23 after having opened the day at $74.05 as compared to the previous trading day's close of $74.26.

Stryker Corporation, a medical technology company, provides reconstructive, medical and surgical, and neurotechnology and spine products for doctors, hospitals, and other healthcare facilities. Stryker Corporation has a market cap of $28.2 billion and is part of the health care sector. The company has a P/E ratio of 31.9, above the S&P 500 P/E ratio of 17.7. Shares are up 35.5% year to date as of the close of trading on Monday. Currently there are 14 analysts that rate Stryker Corporation a buy, 1 analyst rates it a sell, and 10 rate it a hold.

TheStreet Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Stryker Corporation Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, Cigna ( CI) is down $0.92 (-1.1%) to $86.25 on light volume. Thus far, 426,659 shares of Cigna exchanged hands as compared to its average daily volume of 1.7 million shares. The stock has ranged in price between $86.21-$87.04 after having opened the day at $87.04 as compared to the previous trading day's close of $87.17.

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $24.2 billion and is part of the health care sector. The company has a P/E ratio of 13.3, below the S&P 500 P/E ratio of 17.7. Shares are up 63.6% year to date as of the close of trading on Monday. Currently there are 9 analysts that rate Cigna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Cigna Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, Aetna ( AET) is down $0.93 (-1.4%) to $67.53 on light volume. Thus far, 985,133 shares of Aetna exchanged hands as compared to its average daily volume of 2.9 million shares. The stock has ranged in price between $67.46-$68.34 after having opened the day at $68.34 as compared to the previous trading day's close of $68.46.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $25.3 billion and is part of the health care sector. The company has a P/E ratio of 14.0, below the S&P 500 P/E ratio of 17.7. Shares are up 47.8% year to date as of the close of trading on Monday. Currently there are 11 analysts that rate Aetna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, attractive valuation levels, good cash flow from operations and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Aetna Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Baxter International ( BAX) is down $0.86 (-1.3%) to $67.31 on light volume. Thus far, 1.2 million shares of Baxter International exchanged hands as compared to its average daily volume of 3.6 million shares. The stock has ranged in price between $67.17-$68.18 after having opened the day at $68.18 as compared to the previous trading day's close of $68.17.

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $37.1 billion and is part of the health care sector. The company has a P/E ratio of 17.3, below the S&P 500 P/E ratio of 17.7. Shares are up 2.3% year to date as of the close of trading on Monday. Currently there are 5 analysts that rate Baxter International a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, expanding profit margins, notable return on equity and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Baxter International Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, UnitedHealth Group ( UNH) is down $1.10 (-1.5%) to $73.06 on light volume. Thus far, 1.8 million shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 5.1 million shares. The stock has ranged in price between $72.92-$74.14 after having opened the day at $74.14 as compared to the previous trading day's close of $74.16.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $75.0 billion and is part of the health care sector. The company has a P/E ratio of 14.1, below the S&P 500 P/E ratio of 17.7. Shares are up 36.7% year to date as of the close of trading on Monday. Currently there are 13 analysts that rate UnitedHealth Group a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, attractive valuation levels, good cash flow from operations and growth in earnings per share. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full UnitedHealth Group Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

European and U.S. Stocks Called Higher as Earnings Season Hits Full-Speed

European and U.S. Stocks Called Higher as Earnings Season Hits Full-Speed

3 Things Investors Must Know for Monday

3 Things Investors Must Know for Monday

Street Stats: The Mid-Term Elections May Be a Rollercoaster Ride for Investors

Street Stats: The Mid-Term Elections May Be a Rollercoaster Ride for Investors

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC